Grifols (GRFS) Shares Outstanding (Diluted) (2013 - 2025)
Grifols (GRFS) Shares Outstanding (Diluted) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 1.91 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 2.06 Bn |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | 681.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 681.57 Mn |
| Dec 31, 2024 | 679.92 Mn |
| Dec 31, 2023 | 677.10 Mn |
| Dec 31, 2022 | 679.29 Mn |
| Dec 31, 2021 | 681.40 Mn |
| Dec 31, 2020 | 685.14 Mn |
| Sep 30, 2020 | 684.72 Mn |
| Mar 31, 2020 | 684.72 Mn |
| Dec 31, 2019 | 684.72 Mn |
| Sep 30, 2019 | 684.69 Mn |
| Mar 31, 2019 | 684.69 Mn |
| Dec 31, 2018 | 684.69 Mn |
| Sep 30, 2018 | 684.24 Mn |
| Jun 30, 2018 | 684.24 Mn |
| Mar 31, 2018 | 684.24 Mn |
| Dec 31, 2017 | 684.24 Mn |
| Jun 30, 2017 | 684.17 Mn |
| Mar 31, 2017 | 684.17 Mn |
| Dec 31, 2016 | 684.17 Mn |
| Sep 30, 2016 | 683.92 Mn |